4.7 Article

Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

Article Biochemistry & Molecular Biology

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

Wyndham H. Wilson et al.

NATURE MEDICINE (2015)

Article Oncology

Several immune escape patterns in non-Hodgkin's lymphomas

Camille Laurent et al.

ONCOIMMUNOLOGY (2015)

Article Medicine, Research & Experimental

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice

Liufu Deng et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis et al.

NATURE (2010)